Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Clinical trial NCT01258868 · TERMINATED
Trial details
- NCT number
- NCT01258868
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2016-06-13
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.